CERO - CERO THERAPEUTICS HOLDINGS, INC.
0.0951
-1.695 -1,782.229%
Share volume: 45,096,838
Last Updated: 10-30-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$1.79
-1.69
-0.95%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 08-14-2024 | 11-20-2024 | 05-15-2025 | 11-19-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | |||
| Operating expenses | 5.779 M | 4.402 M | 4.951 M | 4.363 M | |
| Selling general and admin | 3.065 M | 2.628 M | 2.043 M | 1.976 M | |
| Research and development | 2.714 M | 1.774 M | 2.908 M | 2.386 M | |
| Total expenses | 5.779 M | 4.402 M | 4.951 M | 4.363 M | |
| -23.82% | 12.45% | -11.88% | |||
| Operating income | -5.148 M | -4.402 M | -4.951 M | -4.363 M | |
| Ebit | -1.801 M | -4.232 M | -5.107 M | -4.362 M | |
| Pretax income | -2.449 M | -4.228 M | -5.106 M | -4.856 M | |
| 72.66% | 20.77% | -4.89% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -2.449 M | -4.228 M | -5.106 M | -4.856 M | |
| -72.66% | -20.77% | 4.89% |